NASDAQ:ESRX - Nasdaq - US30219G1085
92.33
-3.47 (-3.62%)
The current stock price of ESRX is 92.33 null. In the past month the price decreased by -3.11%. In the past year, price increased by 23.88%.
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
EXPRESS SCRIPTS HLDG CO
ONE EXPRESS WAY
SAINT LOUIS MO 63121
CEO: Timothy Wentworth
Phone: 314-996-0900
The current stock price of ESRX is 92.33 null. The price decreased by -3.62% in the last trading session.
The exchange symbol of EXPRESS SCRIPTS HLDG CO is ESRX and it is listed on the Nasdaq exchange.
ESRX stock is listed on the Nasdaq exchange.
EXPRESS SCRIPTS HLDG CO (ESRX) has a market capitalization of 52.06B null. This makes ESRX a Large Cap stock.
EXPRESS SCRIPTS HLDG CO (ESRX) has a support level at 92.32 and a resistance level at 95.05. Check the full technical report for a detailed analysis of ESRX support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ESRX does not pay a dividend.
The PE ratio for EXPRESS SCRIPTS HLDG CO (ESRX) is 10.76. This is based on the reported non-GAAP earnings per share of 8.58 and the current share price of 92.33 null. Check the full fundamental report for a full analysis of the valuation metrics for ESRX.
ChartMill assigns a technical rating of 3 / 10 to ESRX. When comparing the yearly performance of all stocks, ESRX is one of the better performing stocks in the market, outperforming 93.2% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to ESRX. While ESRX belongs to the best of the industry regarding profitability, there are concerns on its financial health.
Over the last trailing twelve months ESRX reported a non-GAAP Earnings per Share(EPS) of 8.58. The EPS increased by 25.44% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 4.83% | ||
ROA | 8.84% | ||
ROE | 23.82% | ||
Debt/Equity | 0.63 |